Evidence Level
Preliminary
Caralluma fimbriata has a plausible mechanism (pregnane glycosides affecting appetite pathways) and a long traditional use history in India. Clinical evidence is limited to a few small trials showing modest appetite suppression and waist circumference reduction. No significant weight loss has been demonstrated. It may be useful as part of a broader appetite management strategy.